Sepsis
644 results
1 - 100
Sepsis 
Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock- De‐escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock
Neonatal early-onset sepsis calculator associated with decreased antibiotic use and no increase in sepsis- Antibiotic regimens for suspected early neonatal sepsis
- Vancomycin for prophylaxis against sepsis in preterm neonates
- Corticosteroids for treating sepsis
- Effectiveness and safety of procalcitonin evaluation for reducing mortality in adults with sepsis, severe sepsis or septic shock
- Antibiotic regimens for early‐onset neonatal sepsis
- High‐volume haemofiltration for sepsis in adults
- Antibiotic regimens for late‐onset neonatal sepsis
- Antibiotic regimens for suspected late onset sepsis in newborn infants
- Recombinant human activated protein C for severe sepsis in neonates
- Corticosteroids for treating sepsis in children and adults
- Drotrecogin alfa for severe sepsis in adults
- Pentoxifylline for treatment of sepsis and necrotising enterocolitis in neonates
- Human recombinant activated protein C for severe sepsis
- Enteral lactoferrin for the treatment of sepsis and necrotizing enterocolitis in neonates
- N‐acetylcysteine for sepsis and systemic inflammatory response in adults
- Plasma interleukin‐6 concentration for the diagnosis of sepsis in critically ill adults
- Corticosteroids decrease 28-day mortality in adults with severe sepsis
- No mortality benefit with albumin administration in severe sepsis (ALBIOS)
- Intravenous immunoglobulin for treating sepsis and septic shock
- Molecular assays for the diagnosis of sepsis in neonates: a diagnostic test accuracy review
- Shenfu injections for sepsis: shorter ICU stays, but no mortality benefit
- Improved 28-day mortality with the use of steroids in sepsis
- Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants
- Reduced sensitivity of blood cultures after initiating antibiotics for severe sepsis
- Combination of beta lactam and aminoglycoside antibiotic therapy for sepsis
- Accuracy of procalcitonin for sepsis diagnosis in critically ill patients
- Lower transfusion threshold for sepsis = fewer transfusions, no effect on mortality
- Herbal infusion seems effective in reducing risk of death from sepsis (EXIT-SEP)
- Early versus late pre‐intensive care unit admission broad spectrum antibiotics for severe sepsis in adults
- Human recombinant protein C for severe sepsis and septic shock in adult and paediatric patients
- Liberal versus conservative fluid therapy in adults and children with sepsis or septic shock
- New definition of sepsis, new bedside screen to identify patients at high-mortality risk
- Vancomycin + piperacillin-tazobactam associated with greater mortality than vancomycin + cefepime in patients with sepsis
- No difference in outcomes with restrictive versus liberal fluid strategy for sepsis-induced hypotension
- Granulocyte transfusions for neonates with confirmed or suspected sepsis and neutropenia: Cochrane systematic review
- Automated monitoring compared to standard care for the early detection of sepsis in critically ill patients
- Effectiveness and safety of procalcitonin evaluation for reducing mortality in adults with sepsis
- SR: poor quality evidence on outcomes of lactate point-of-care testing in patients with suspected sepsis
- Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis: Cochrane systematic review
- Early initiation of RRT does not improve mortality in patients with sepsis and severe acute kidney injury
- Umbilical cord antiseptics for preventing sepsis and death among newborns
- Methods of preventing bacterial sepsis and wound complications after liver transplantation: Cochrane systematic review
- One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates
- No reduction in mortality with continuous vs intermittent infusion of beta-lactam antibiotics for critically ill patients with sepsis (BLING-III)
- No clear advantage to balanced crystalloids over saline; though 1 study suggests a mortality benefit in patients with sepsis